PIK3CA and non-small cell lung carcinoma: A study screening NSCLC, SCLC, extrapulmonary small cell cancer cell lines, and resected NSCLC identified PIK3CA gain in 33.1 and 6.2% of squamous and adenocarcinoma, respectively (92).